mayo clinic glp 1 oral solution GLP-1s STDEI GLP-1 Weight Loss Review

GLP-1 + GIP treatments should not be used by individuals with a personal or family history of MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)

doi:10.1007/s40262-017-0528-2 23

Adults can now only receive the medication if it is deemed medically necessary for conditions such as Type 2 diabetes, heart disease or chronic kidney disease

Mark Pimentel, MD, Executive Director of the Medically Associated Science and Technology Program at Cedars-Sinai, and a leading expert on microbial overgrowths, puts it this way: Any factor that slows down the speed of flow [of food] through the small intestine has the potential to cause [bacterial] overgrowth. This is important for patients assessing their SIBO risk, because studies suggest GLP-1 signaling can inhibit aspects of the Migrating Motor Complex (MMC)

2025 July

Manufacturers are responsible for ensuring safety and accurate labeling, but supplements cannot legally claim to treat, cure, or prevent any disease